Technical Analysis for AMRX - Amneal Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 5.89 7.09% 0.39
AMRX closed up 1.51 percent on Friday, March 8, 2024, on 71 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 9.28%
Calm After Storm Range Contraction 10.92%
NR7 Range Contraction 10.92%
Narrow Range Bar Range Contraction 10.92%
Inside Day Range Contraction 10.92%
Calm After Storm Range Contraction 10.92%
Lower Bollinger Band Walk Weakness 10.92%
Down 3 Days in a Row Weakness 10.92%
Down 4 Days in a Row Weakness 10.92%
Down 5 Days in a Row Weakness 10.92%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 16 hours ago
Up 1 ATR about 20 hours ago
Up 5% about 21 hours ago
Rose Above 20 DMA about 21 hours ago
60 Minute Opening Range Breakout about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amneal Pharmaceuticals, Inc. Description

Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Impax Generics and Impax Specialty Pharma. The Impax Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Impax Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Health Sciences Drugs Pharmaceutical Products Parkinson's Disease Drug Products Treatment Of Parkinson's Disease Migraine Headache Generic Drug Treatment Of Migraine Migraine Headache Carbidopa L Dopa Migraine Headaches

Is AMRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.3
52 Week Low 1.245
Average Volume 1,330,124
200-Day Moving Average 4.24
50-Day Moving Average 5.61
20-Day Moving Average 5.62
10-Day Moving Average 5.48
Average True Range 0.27
RSI (14) 43.82
ADX 12.97
+DI 25.05
-DI 17.51
Chandelier Exit (Long, 3 ATRs) 5.34
Chandelier Exit (Short, 3 ATRs) 5.82
Upper Bollinger Bands 6.02
Lower Bollinger Band 5.22
Percent B (%b) 0.21
BandWidth 14.20
MACD Line -0.06
MACD Signal Line -0.01
MACD Histogram -0.0496
Fundamentals Value
Market Cap 1.65 Billion
Num Shares 307 Million
EPS 0.06
Price-to-Earnings (P/E) Ratio 89.83
Price-to-Sales 0.72
Price-to-Book 5.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.74
Resistance 3 (R3) 5.74 5.63 5.68
Resistance 2 (R2) 5.63 5.54 5.63 5.66
Resistance 1 (R1) 5.51 5.49 5.57 5.51 5.64
Pivot Point 5.40 5.40 5.43 5.40 5.40
Support 1 (S1) 5.28 5.31 5.34 5.28 5.14
Support 2 (S2) 5.17 5.26 5.17 5.12
Support 3 (S3) 5.05 5.17 5.10
Support 4 (S4) 5.05